Author Login IJIRT Partner Network (IPN) Login

The Pharmacology of Neuroprotection: A Review of Drugs and Targets for Neurodegenerative Diseases

  • Unique Paper ID: 166670
  • Volume: 11
  • Issue: 2
  • PageNo: 1520-1524
  • Abstract:
  • Neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS), are characterized by progressive neuronal loss and functional decline. The development of neuroprotective strategies aims to prevent or slow this neurodegeneration. This review discusses the current pharmacological agents and their molecular targets for neuroprotection in these diseases, focusing on antioxidants, mitochondrial protectants, glutamate receptor antagonists, anti-inflammatory agents, neurotrophic factors, cholinesterase inhibitors, immunomodulatory therapies, autophagy modulators, epigenetic modifiers, calcium channel blockers, stem cell therapy, and gene therapy. Advances in clinical trials, combination therapies, biomarker development, and precision medicine are also explored.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 11
  • Issue: 2
  • PageNo: 1520-1524

The Pharmacology of Neuroprotection: A Review of Drugs and Targets for Neurodegenerative Diseases

Related Articles

09 Jul, 2024

FORMULATION AND DEVELOPMENT OF ANTI AGEING CREAM BY HERBAL EXTRACT OF POMEGRANATE AND BECLOMETASONE

Read More
Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry